Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 
applications

Labuhn, Maurice; Adams, Felix F.; Ng, Michelle; Knoess, Sabine; Schambach, Axel; Charpentier, Emmanuelle M.; Schwarzer, Adrian; Mateo, Juan L.; Klusmann, Jan-Henning; Heckl, Dirk

doi:10.1093/nar/gkx1268

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications

MPS-Authors

/persons/resource/persons194799

Charpentier, Emmanuelle M.
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Nucl_Acids_Res_2018_46_1375.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Labuhn, M., Adams, F. F., Ng, M., Knoess, S., Schambach, A., Charpentier, E. M., et al. (2018). Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications. Nucleic Acids Research (London), 46(3), 1375-1385. doi:10.1093/nar/gkx1268.

Cite as: https://hdl.handle.net/21.11116/0000-0001-2F5E-3

Abstract

There is no abstract available